Press Release (ePRNews.com) - SAN FRANCISCO, Calif. - Aug 01, 2017 - Precise.ly, Inc., (formerly We Are Curious, Inc.) a personal health data integrator and social platform, announced its expansion into genetics through its partnership with Helix, who launched the first online marketplace for DNA-powered products July 24.
“We are very pleased to be partnered with Helix, enabling the addition of selected genetic data to our customers’ health portfolios,” said Linda Avey, Precise.ly co-founder & CEO. “Their model allows us to cater to disease communities in ways we hope will further the knowledge of complex conditions, by uniquely combining genetic data with other tracked symptoms, treatments, and environmental exposures, both current and past.”
Precise.ly’s first Helix product is designed for broad appeal. Based on an individual’s genetic data at specific points in his or her genome, it generates an avatar that can be easily compared to others’. “We wanted to create something that everyone can relate to. It creates a fun way for people to connect, discover similarities and start conversations, regardless of gender, ethnic background, or state of health,” said Avey.
“We are looking forward to the breadth of products that Precise.ly will be bringing to the Helix marketplace,” said Justin Kao, co-founder and SVP of Helix. “A core part of our business model is engaging with innovative developers who have creative ways of bringing DNA to life, and Precise.ly’s mission of combining DNA with other important personal data sets will do just that.”
Precise.ly is a personal data tracking and integrating platform, comprised of web and app-based tools designed to streamline the importing of data from wearables, genome sequencing, environmental monitors, and the diversity of dynamically tracked events and activities. Users and researchers can create group tracking protocols, with consented data-sharing options. Its mission is to help individuals achieve precision health through personal data.
Precise.ly was co-founded in 2011 by Linda Avey, Mitsu Hadeishi, and Heather Anne Halpert.
Helix is a personal genomics company with a simple but powerful mission: to empower every person to improve their life through DNA. We’ve created the first marketplace for DNA-powered products where people can explore diverse and uniquely personalized products developed by high-quality partners. Helix handles sample collection, DNA sequencing, and secure data storage so that our partners can integrate DNA insights into products across a range of categories, including ancestry, entertainment, family, fitness, health and nutrition. From profound insights to just-for-fun discoveries, Helix is here to help people live a fuller life. Helix is headquartered in the San Francisco Bay Area, and has a CLIA- and CAP-accredited Next Generation Sequencing lab powered by Illumina (NASDAQ:ILMN) NGS technology, in San Diego. Helix was created in 2015 with founding support from Illumina, its largest shareholder. Learn more at www.helix.com.
Helix, the Helix logo and Exome+ are trademarks of Helix Opco, LLC. All other trademarks referenced herein are the property of their respective owners.
DISCLAIMER : If you have any concerns regarding this press release, please contact the Author / Media Contact / Business of this press release. ePRNews is not resposible for the accuracy of the news posted and do not endorse, support any product/services/business mentioned and hereby disclaims any content contained in this press release.